Cancer Research · 2020 · 52 citations · 37 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor MicroenvironmentCancer Cell SignalingCancer EpigeneticsEpigenetic Regulation In CancerMetastatic Breast CancerNotch SignalingOncogenic Signaling PathwaysCancer Cell Survival SignalingCancer Signaling PathwaysMetastatic MicroenvironmentMetastatic SignalingMetastatic Tumor MicroenvironmentOncogenic Signaling NetworksTherapeutic EpigeneticsTumor Microenvironment Epigenetics
Current cancer treatments are largely based on the genetic characterization of primary tumors and are ineffective for metastatic disease. Here we report that DNA methyltransferase 3B (DNMT3B) is induced at distant metastatic sites and mediates epigenetic reprogramming of metastatic tumor cells. Multiomics analysis and spontaneous metastatic mouse models revealed that DNMT3B alters multiple pathways including STAT3, NFκB, PI3K/Akt, β-catenin, and Notch signaling, which are critical for cancer cell survival, apoptosis, proliferation, invasion, and colonization. PGE2 and IL6 were identified as critical inflammatory mediators in DNMT3B induction. DNMT3B expression levels positively correlated with human metastatic progression. Targeting IL6 or COX-2 reduced DNMT3B induction and improved chemo or PD1 therapy. We propose a novel mechanism linking the metastatic microenvironment with epigenetic alterations that occur at distant sites. These results caution against the "Achilles heel" in cancer therapies based on primary tumor characterization and suggests targeting DNMT3B induction as new option for treating metastatic disease. SIGNIFICANCE: These findings reveal that DNMT3B epigenetically regulates multiple pro-oncogenic signaling pathways via the inflammatory microenvironment at distant sites, cautioning the clinical approach basing current therapies on genetic characterization of primary tumors.
37
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine · 2018 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang, Han Han, Daniel D. De Carvalho et al. · Cancer Cell · 2014 · 1.2K citations · Full text
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Ina Rhee, Kurtis E. Bachman, Ben Ho Park et al. · Nature · 2002 · 1.2K citations
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim, Ruli Gao, Emi Sei et al. · Cell · 2018 · 1.2K citations